Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,024+, returning 3,640%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 3,639.96% |
Mobile Global Esports (MGAM) | 1,650% |
Janover Inc Common Stock (JNVR) | 1,258.6% |
Diginex Limited Ordinary Shares (DGNX) | 1,191.55% |
Oncology Institute (TOI) | 798.69% |
Top KingWin (WAI) | 610.53% |
Asset Entities Inc Class B Common Stock (ASST) | 578% |
Dominari (DOMH) | 492.55% |
Protagenic Therapeutics (PTIX) | 474.67% |
Global Interactive Technologies (GITS) | 468.46% |
NETCLASS TECHNOLOGY INC Class A Ordinary Shares (NTCL) | 456.68% |
Oriental Culture Holding (OCG) | 448.35% |
Yoshiharu Global (YOSH) | 395% |
Regulus Therapeutics (RGLS) | 390.63% |
ThredUp (TDUP) | 347.22% |
CuriosityStream (CURIW) | 321.67% |
Mobile-health Network Solutions Class A Ordinary Shares (MNDR) | 318.45% |
Abits (ABTS) | 301.25% |
Twin Hospitality (TWNP) | 294.38% |
CervoMed (CRVO) | 271.25% |
Arena (AREN) | 269.57% |
Nutex Health (NUTX) | 266.59% |
Marblegate Acquisition (GATE) | 229.22% |
Upexi (UPXI) | 219.17% |
Curiositystream (CURI) | 207.5% |
